| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case study of development, validation, and acceptance of a non-animal method for assessing human vaccine potency
|
Descamps, Johan
|
|
2011
|
5 |
C |
p. 184-191
8 p.
|
artikel
|
| 2 |
Alternative methods and strategies to reduce, refine, and replace animal use for human vaccine post-licensing safety testing: state of the science and future directions
|
Isbrucker, Richard
|
|
2011
|
5 |
C |
p. 47-59
13 p.
|
artikel
|
| 3 |
Alternative methods and strategies to reduce, refine, and replace animal use for veterinary vaccine post-licensing safety testing: state of the science and future directions
|
Kulpa-Eddy, Jodie
|
|
2011
|
5 |
C |
p. 106-119
14 p.
|
artikel
|
| 4 |
Alternative Methods to Reduce, Refine, and Replace the Use of Animals In the Development and Testing of Veterinary Biologics in The United States; a Strategic Priority
|
Hill, Richard E.
|
|
2011
|
5 |
C |
p. 141-145
5 p.
|
artikel
|
| 5 |
Animal Refinement and Reduction: Alternative Approaches for Potency Testing of Diphtheria and Tetanus Vaccines
|
Stickings, Paul
|
|
2011
|
5 |
C |
p. 200-212
13 p.
|
artikel
|
| 6 |
Application of the consistency approach to reduce animal use in vaccine potency testing
|
Kulpa-Eddy, Jodie
|
|
2011
|
5 |
C |
p. 232-235
4 p.
|
artikel
|
| 7 |
Approaches to reducing animal numbers in vaccine potency testing
|
Kulpa-Eddy, Jodie
|
|
2011
|
5 |
C |
p. 227-231
5 p.
|
artikel
|
| 8 |
Case study of development, validation, and acceptance of a non-animal method for assessing veterinary vaccine potency
|
Claassen, Ivo
|
|
2011
|
5 |
C |
p. 175-183
9 p.
|
artikel
|
| 9 |
Contents
|
|
|
2011
|
5 |
C |
p. iii-iv
nvt p.
|
artikel
|
| 10 |
Development and validation of serological methods for human vaccine potency testing: Case study of an anthrax vaccine
|
Arciniega, Juan L
|
|
2011
|
5 |
C |
p. 213-220
8 p.
|
artikel
|
| 11 |
European Regulatory Requirements for Veterinary Vaccine Safety and Potency Testing and Recent Progress Towards Reducing Animal Use
|
Woodland, Ralph
|
|
2011
|
5 |
C |
p. 151-155
5 p.
|
artikel
|
| 12 |
Health Canada's human vaccine lot release program: impact on the 3Rs
|
Isbrucker, Richard
|
|
2011
|
5 |
C |
p. 147-150
4 p.
|
artikel
|
| 13 |
Humane endpoints in vaccine potency testing
|
Hendriksen, Coenraad F.M.
|
|
2011
|
5 |
C |
p. 221-226
6 p.
|
artikel
|
| 14 |
Human Vaccines and Their Importance to Public Health
|
Schuchat, Anne
|
|
2011
|
5 |
C |
p. 120-126
7 p.
|
artikel
|
| 15 |
Improving animal welfare and reducing animal use for human vaccine potency testing: state of the science and future directions
|
Casey, Warren
|
|
2011
|
5 |
C |
p. 33-46
14 p.
|
artikel
|
| 16 |
Improving animal welfare and reducing animal use for veterinary vaccine potency testing: state of the science and future directions
|
Stokes, William S
|
|
2011
|
5 |
C |
p. 84-105
22 p.
|
artikel
|
| 17 |
International regulatory requirements for vaccine safety and potency testing: a WHO perspective&
|
Shin, Jinho
|
|
2011
|
5 |
C |
p. 164-170
7 p.
|
artikel
|
| 18 |
Non-animal replacement methods for human vaccine potency testing: state of the science and future directions
|
McFarland, Richard
|
|
2011
|
5 |
C |
p. 16-32
17 p.
|
artikel
|
| 19 |
Non-animal replacement methods for veterinary vaccine potency testing: state of the science and future directions
|
Kulpa-Eddy, Jodie
|
|
2011
|
5 |
C |
p. 60-83
24 p.
|
artikel
|
| 20 |
Overview of Currently Approved Serological Methods with a Focus On Diphtheria and Tetanus Toxoid Potency Testing
|
Keller, James E.
|
|
2011
|
5 |
C |
p. 192-199
8 p.
|
artikel
|
| 21 |
Overview of currently approved veterinary vaccine potency testing methods and methods in development that do not require animal use
|
Draayer, Hans
|
|
2011
|
5 |
C |
p. 171-174
4 p.
|
artikel
|
| 22 |
Strategic Approaches for Developing Alternative Tests for Safety and Potency of Vaccines
|
Horiuchi, Yoshinobu
|
|
2011
|
5 |
C |
p. 156-163
8 p.
|
artikel
|
| 23 |
Target alternative vaccine safety testing strategies for pertussis toxin
|
Arciniega, Juan L
|
|
2011
|
5 |
C |
p. 248-260
13 p.
|
artikel
|
| 24 |
The International Workshop on Alternative Methods to Reduce, Refine, and Replace the Use of Animals in Vaccine Potency and Safety Testing: introduction and summary
|
Stokes, William S
|
|
2011
|
5 |
C |
p. 1-15
15 p.
|
artikel
|
| 25 |
Toward replacement of the monkey neurovirulence test in vaccine safety testing
|
Rubin, Steven A
|
|
2011
|
5 |
C |
p. 261-265
5 p.
|
artikel
|
| 26 |
U.S. FDA requirements for Human Vaccine Product Safety and Potency Testing
|
Finn, Theresa M
|
|
2011
|
5 |
C |
p. 137-140
4 p.
|
artikel
|
| 27 |
Veterinary vaccine post-licensing safety testing: overview of current regulatory requirements and accepted alternatives
|
Gifford, Glen
|
|
2011
|
5 |
C |
p. 236-247
12 p.
|
artikel
|
| 28 |
Veterinary Vaccines and Their Importance to Animal Health and Public Health
|
Roth, James A
|
|
2011
|
5 |
C |
p. 127-136
10 p.
|
artikel
|
Tijdschrift beschrijving